Free Trial

NexgenRx Q1 2024 Earnings Report

C$0.25 -0.03 (-10.71%)
As of 04/2/2025 02:15 PM Eastern

NexgenRx EPS Results

Actual EPS
C$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NexgenRx Revenue Results

Actual Revenue
$4.29 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NexgenRx Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Remove Ads

NexgenRx Earnings Headlines

Gold Hits $3,000… Here’s How You Can Get More for Under $20
With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively stockpiling gold at any price, the market is showing no signs of slowing down. In fact, gold has recently reached new all-time highs, driven by expectations of interest rate cuts and increasing safe-haven demand. This trend has led to a significant boost in gold mining stocks and gold-focused investment funds. But here's the exciting part: I've found a way to get exposure to MORE than an ounce of gold for under $20.
NexgenRX Inc.
Closing Bell: Nexgenrx Inc up on Monday (NXG)
See More NexgenRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NexgenRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NexgenRx and other key companies, straight to your email.

About NexgenRx

NexgenRx (CVE:NXG) administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

View NexgenRx Profile

More Earnings Resources from MarketBeat